Literature DB >> 8285811

Acquired risk factors for deep-vein thrombosis in symptomatic outpatients.

A Cogo1, E Bernardi, P Prandoni, B Girolami, F Noventa, P Simioni, A Girolami.   

Abstract

BACKGROUND: Epidemiologic studies on deep-vein thrombosis (DVT) have been mainly confined to the inpatient population. The aim of this study was to investigate the association between DVT and acquired risk factors in a large cohort of outpatients with clinically suspected DVT.
METHODS: Consecutive outpatients with clinically suspected DVT were enrolled in the study. Before objective testing, all patients were interviewed by a trained physician for the presence of risk factors for DVT development. Subsequently, the presence or absence of DVT was assessed with venography.
RESULTS: Approximately 50% of cases of DVT were considered to be secondary to a major risk factor (immobilization, trauma, and/or recent surgery). Among additional risk factors, only increased age (over 60 years), male gender, malignant neoplasm, heart failure, systemic lupus erythematosus, and arteriopathy were independently associated with the risk of acute DVT.
CONCLUSION: Major risk factors for venous thromboembolism are a common cause of DVT among symptomatic outpatients; therefore, the usefulness of extending DVT prophylaxis in the outpatient setting should be tested. The role of additional risk factors in the development of DVT needs to be established by properly designed studies.

Entities:  

Mesh:

Year:  1994        PMID: 8285811

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  32 in total

1.  [Special aspects for preventing thromboembolism in surgical dermatology].

Authors:  R Rompel; E Rabe; I Hackert; G Sebastian
Journal:  Hautarzt       Date:  2002-03       Impact factor: 0.751

Review 2.  Risk-assessment algorithm and recommendations for venous thromboembolism prophylaxis in medical patients.

Authors:  Ana T Rocha; Edison F Paiva; Arnaldo Lichtenstein; Rodolfo Milani; Cyrillo Filho Cavalheiro; Francisco H Maffei
Journal:  Vasc Health Risk Manag       Date:  2007

Review 3.  The post-thrombotic syndrome: the forgotten morbidity of deep venous thrombosis.

Authors:  Susan R Kahn
Journal:  J Thromb Thrombolysis       Date:  2006-02       Impact factor: 2.300

4.  Risk factors for incident venous thromboembolism in active cancer patients: A population based case-control study.

Authors:  Aneel A Ashrani; Rachel E Gullerud; Tanya M Petterson; Randolph S Marks; Kent R Bailey; John A Heit
Journal:  Thromb Res       Date:  2016-01-05       Impact factor: 3.944

5.  Rapid occurrence of left ventricular thrombus associated with platinum-based chemotherapy plus cetuximab for the treatment of metastatic squamous cell carcinoma of the head and neck: A case report.

Authors:  Atsushi Ikeda; Eiki Yamachika; Masahide Mizutani; Masakazu Matsubara; Norifumi Moritani; Kazuki Nakatsuji; Seiji Iida
Journal:  Mol Clin Oncol       Date:  2017-08-25

6.  The Prophylaxis of Venous Thromboembolism.

Authors:  Albrecht Encke; Sylvia Haas; Ina Kopp
Journal:  Dtsch Arztebl Int       Date:  2016-08-08       Impact factor: 5.594

7.  Is lipid lowering therapy an independent risk factor for venous thromboembolism? A population-based case-control study.

Authors:  Aneel A Ashrani; Michel K Barsoum; Daniel J Crusan; Tanya M Petterson; Kent R Bailey; John A Heit
Journal:  Thromb Res       Date:  2015-04-11       Impact factor: 3.944

8.  Prevalence of risk factors for venous thromboembolism in the Italian population: results of a cross-sectional study from the Master Registry.

Authors:  Walter Ageno; Giancarlo Agnelli; Davide Imberti; Marco Moia; Gualtiero Palareti; Riccardo Pistelli; Melina Verso
Journal:  Intern Emerg Med       Date:  2011-06-10       Impact factor: 3.397

9.  Multisegmental anomaly of the inferior vena cava with thrombosis of the left inferior vena cava.

Authors:  H Saito; N Sano; I Kaneda; M Arakawa; S Ishida; S Takahashi; K Sakamoto
Journal:  Cardiovasc Intervent Radiol       Date:  1995 Nov-Dec       Impact factor: 2.740

10.  Risk of venous thromboembolism among hospitalizations of adults with selected autoimmune diseases.

Authors:  Hussain R Yusuf; W Craig Hooper; Michele G Beckman; Qing C Zhang; James Tsai; Thomas L Ortel
Journal:  J Thromb Thrombolysis       Date:  2014-10       Impact factor: 2.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.